ACI’s Hatch-Waxman Series Advisory Board
American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.
Advisory Board
Ryan M. Daniel
VP, Associate General Counsel, Corporate and Business Transactions Biopharmaceuticals Fresenius Kabi, LLC
Laura DeMoor
Associate General Counsel, IP Baxter Healthcare Corporation
Stephanie Donahue
Head of Global Patent LitigationGlobal Intellectual Property Department
Legal, Ethics & Business Integrity Sanofi
Serena Farquharson Torres
Executive Director, Assistant General Counsel Bristol Myers Squibb
Linda Friedlieb
Division Counsel AbbVie
Colin Heitzmann
Vice President, Intellectual Property and BusinessDevelopment, Legal and Corporate Affairs Daiichi Sankyo, Inc.
Jenny Papatolis Johnson
VP, Assistant General Counsel, IP Endo Pharmaceuticals
Staci Julie
SVP and Chief IP Counsel Teva Pharmaceuticals
Neema Kumar
Vice President, IP, North America Sandoz
Mary Morry
Counsel, IP Litigation Merck & Company
Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel Pfizer Inc
Aaron Pereira
Senior Director of Patents Ferring Pharmaceuticals
Lars P. Taavola
Vice President, Chief Intellectual Property Counsel & General Counsel, Brands Mallinckrodt Pharmaceuticals
Andrea Tiglio
Executive DirectorAssistant General Counsel, IP Jazz Pharmaceuticals
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Government Affairs Amneal Pharmaceuticals
Kevin Zive
Vice President, Global General Counsel,Head of IP Apotex Inc.
Emeritus Members
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation Taft Stettinius & Hollister LLP(Former Vice President, IP, Sandoz, Inc.)
Guy Donatiello
Former SVP of IP Endo Pharmaceuticals
George W. Johnston
Counsel Gibbons P.C.(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)
Honorable Kathleen M. O’Malley (Ret.)
Of Counsel Sullivan & Cromwell LLP
Honorable Teresa Rea
Consultant Rea Consulting LLC Former Acting Director of the USPTO
Shashank Upadhye
Partner Upadhye Tang LLP